Join the Sickle Cell Foundation, Inc. and representatives from NeoImmuneTech Pharmaceuticals, Inc. for “Re-Imaging Endari!”, a virtual roundtable discussion focused on Endari® (L-glutamine oral powder) and its role in sickle cell disease care. Our panel will bring together perspectives from community engagement, clinical development and medical affairs, commercialization, and market access for an informative conversation about Endari®, patient and community needs, access to care, and supporting individuals and families affected by sickle cell disease.

Wednesday, September 23, 2026
2:00 PM Eastern Time Live via Zoom

Featured Panelists:
Karen M. Gant, PhD(c), APRN, FNP-BC — Director, Community Engagement

Joyce Kim, PharmD — Manager, Clinical Development and Medical Affairs

Kazon Neely — Area Business Leader

Steven Frankowitz — Senior Director of Commercialization and Market Access

Registration is required. After registering, you will receive information about joining the Zoom discussion.

Presented by the Sickle Cell Foundation, Inc. in collaboration with NeoImmuneTech Pharmaceuticals, In